Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2022 ∙ Lopez-Olivo, M. A. Valerio, V. Karpes Matusevich, A. R. Brizio, M. Kwok, M. Geng, Y. Suarez-Almazor, M. E. Colmegna, I.
Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis
All age groups Influenza Safety Efficacy/effectiveness
Rating:
Low
2022 ∙ Xu, W. Tang, J. Chen, C. Wang, C. Wen, W. Cheng, Y. Zhou, M. Wu, Q. Zhang, X. Feng, Z. Wang, M.
Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis
Children Adolescents COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Simayi, A. Zhu, L. Jin, H.
Safety and Immunogenicity of Pertussis Vaccine Immunization during Pregnancy: A Meta-Analysis of Randomized Clinical Trials
Pregnant women Pertussis Safety Efficacy/effectiveness
Rating:
Low
2022 ∙ Yeasmin, M. Molla, M. M. A. Masud, H. M. A. A. Saif-Ur-Rahman, K. M.
Safety and immunogenicity of Zika virus vaccine: A systematic review of clinical trials
Adults Zika Safety Efficacy/effectiveness Administration
Rating:
Critically low
2022 ∙ Katoto, P. D. M. C. Brand, A. S. Byamungu, L. N. Tamuzi, J. L. Mahwire, T. C. Kitenge, M. K. Wiysonge, C. S. Gray, G.
Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis
Adolescents COVID-19 Safety
Rating:
Critically low
2022 ∙ Chen, H. Zhang, X. Lin, G. Gong, F. Hocher, B.
Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review
Western Pacific China Adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Zheng, Q. Ma, P. Feng, Z.
Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2022 ∙ James, D. Jena, A. Bharath, P. N. Choudhury, A. Singh, A. K. Sebastian, S. Sharma, V.
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Low
2022 ∙ Ahern, S. Walsh, K. A. Paone, S. Browne, J. Carrigan, M. Harrington, P. Murphy, A. Teljeur, C. Ryan, M.
Safety of varicella vaccination strategies: An overview of reviews
Newborn Children Varicella Administration Safety
Rating:
Not applicable
2022 ∙ Asghar, N. Mumtaz, H. Syed, A. A. Eqbal, F. Maharjan, R. Bamboria, A. Shrehta, M.
Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
Loading...